EPO and anemia: Similar to Nsd1−/−, Spi1 transgenic mice develop anemia, thrombocytopenia, and multi-organ infiltration of erythroblasts progressing from an EPO-dependent stage to EPO-independence by acquisition of activating mutations in the c-kit receptor tyrosine kinase47,48.